{{Rsnum
|rsid=10493485
|Gene=NEGR1
|Chromosome=1
|position=71605446
|Orientation=plus
|GMAF=0.3131
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;T)
|geno3=(T;T)
|Gene_s=NEGR1
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;T)
| geno3=(T;T)
| CEU | 50.4 | 42.5 | 7.1
| HCB | 20.4 | 52.6 | 27.0
| JPT | 18.6 | 48.7 | 32.7
| YRI | 100.0 | 0.0 | 0.0
| ASW | 87.7 | 12.3 | 0.0
| CHB | 20.4 | 52.6 | 27.0
| CHD | 17.4 | 55.0 | 27.5
| GIH | 53.5 | 36.6 | 9.9
| LWK | 93.6 | 6.4 | 0.0
| MEX | 37.9 | 53.4 | 8.6
| MKK | 87.2 | 11.5 | 1.3
| TSI | 53.9 | 35.3 | 10.8
| HapMapRevision=28
}}

{{GWAS Summary
|SNP=rs10493485
|PubMedID=17903294
|Condition=Hemostatic factors and hematological phenotypes
|Gene=NEGR1
|Risk Allele=
|pValue=2.00E-006
|OR=NA
|95CI=
|OA=1
}}

{{PharmGKB
|RSID=rs10493485
|Name_s=
|Gene_s=NEGR1
|Feature=
|Evidence=PubMed ID:17903294; Web Resource:http://www.genome.gov/gwastudies/
|Annotation=GWAS results: Genome-wide association and linkage analyses of hemostatic factors and hematological phenotypes in the Framingham Heart Study (Initial Sample Size: 1,000 individuals (Framingham; Replication Sample Size: NR). This variant is associated with Hemostatic factors and hematological phenotypes.
|Drugs=
|Drug Classes=
|Diseases=Hematologic Diseases
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA162356460
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs10493485
|overall_frequency_n=28
|overall_frequency_d=126
|overall_frequency=0.222222
|n_genomes=20
|n_genomes_annotated=0
|n_haplomes=25
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|in_pharmgkb=Y
|autoscore=2
|webscore=N
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | HumanOmni1Quad}}